INJECT ApS: Financial statements 2022
CVR: 33867581
Source: annual report 2022, Danish Business Authority
01/09/2021 – 31/08/2022
INJECT ApS (CVR 33867581) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2022 report amounted to DKK 0.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 0 | 0 | 0 | - |
| 2021 | 0 | 0 | 0 | 0 | - |
| 2020 | 0 | 0 | 0 | 0 | - |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 1 |
Official annual report
Keep an eye on INJECT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
INJECT ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 0.
About INJECT ApS
INJECT ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2011. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Felix Hetting. The company is owned by MAFO ApS, Tina Hetting Holding I ApS and ASYRINGE LIMITED. According to the 2019 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 0.